A Randomized Trial of the Effects of Dietary n3-PUFAs on Skeletal Muscle Function and Acute Exercise Response in Healthy Older Adults

Nutrients
Q1
Aug 2022
Citations:23
Influential Citations:1
Interventional (Human) Studies
90
S2 IconPDF Icon

Enhanced Details

Methods
Randomized, double-blind, placebo-controlled trial. 63 healthy, independently living older adults aged 65–85 years (mean ~71.4–71.5; 29 male, 34 female).
Intervention
EPA+DHA ~3.9 g/day (4 x 1000 mg softgels; each softgel ~675 mg EPA and ~300 mg DHA). Taken as 2 softgels with morning meals and 2 softgels with evening meals for 6 months.
Results
6 months of EPA+DHA ~3.9 g/day increased knee-extension strength by 7.5% vs 3.1% with placebo (p=0.039). No significant effects on mitochondrial function (respiration, ATP production, ROS) or whole-body/muscle protein metabolism. Acute exercise–related whole-body amino acid kinetics showed attenuation of post-exercise protein synthesis increases; muscle fractional synthesis rate (FSR) increased after exercise in both groups, with an attenuated increase in tissue-fluid–FSR in the n3-PUFA group. RBC EPA/DHA increased in the active group, confirming adherence. Interpretation: modest muscle-strength benefits in healthy older adults; no clear metabolic or mitochondrial improvements; potential greater benefit in older adults with inflammation or sarcopenia; further research needed.
Limitations
Healthy, nonfrail older adults; limited generalizability to frail or inflamed populations; sample size moderate; 6 months duration; potential learning effects in strength testing; small lean-mass changes may be underestimated by DXA; mitochondrial measures in permeabilized fibers may not reflect whole-organism function.

Abstract

Skeletal muscle is critical for maintaining mobility, independence, and metabolic health in older adults. However, a common feature of aging is the progressive loss of skeletal muscle mass and function, which is often accompanied by mitochondrial imp...